STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGL
  4. [Form 4] agilon health, inc. Insider Trading Activity

agilon health (NYSE: AGL) CAO reports RSU tax-withholding share transactions

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

agilon health, inc. Chief Accounting Officer Timothy Gertsch reported two Form 4 transactions in Common Stock. On April 15, 2026, 122 shares were withheld at $26.88 per share, and on April 14, 2026, 25 shares were withheld at $22.68 per share to satisfy tax obligations from restricted stock unit settlements. These transactions did not involve open-market sales, and Gertsch held 14,177 shares of Common Stock directly after the most recent transaction.

Positive

  • None.

Negative

  • None.
Insider Gertsch Timothy
Role Chief Accounting Officer
Type Security Shares Price Value
Tax Withholding Common Stock 122 $26.88 $3K
Tax Withholding Common Stock 25 $22.68 $567.00
Holdings After Transaction: Common Stock — 14,177 shares (Direct)
Footnotes (1)
  1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. Includes restricted stock units.
Shares withheld for taxes (total) 147 shares Tax-withholding dispositions related to RSU settlements
Shares withheld on April 15, 2026 122 shares at $26.88/share Tax-withholding disposition of Common Stock
Shares withheld on April 14, 2026 25 shares at $22.68/share Tax-withholding disposition of Common Stock
Shares held after latest transaction 14,177 shares Direct Common Stock ownership following tax withholding
restricted stock units financial
"in connection with the net settlement of the restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
net settlement financial
"in connection with the net settlement of the restricted stock units"
income tax withholding financial
"withheld by the issuer to satisfy its income tax withholding and remittance obligations"
Form 4 regulatory
"The Form 4 shows Timothy Gertsch had shares of agilon health Common Stock withheld"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Chief Accounting Officer financial
"Timothy Gertsch is identified as the Chief Accounting Officer of agilon health, inc."
A chief accounting officer is a senior executive responsible for overseeing a company's financial records and ensuring all accounting practices are accurate and compliant with regulations. They play a key role in preparing financial reports that help investors understand the company's financial health, much like a trusted navigator guiding a ship through complex waters. Their work ensures transparency and trust in the company's financial information.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gertsch Timothy
(Last)(First)(Middle)
C/O AGILON HEALTH, INC.
440 POLARIS PARKWAY, SUITE 550
(Street)
WESTERVILLE OHIO 43082
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/14/2026F25(1)D$22.6814,299D
Common Stock04/15/2026F122(1)D$26.8814,177(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
2. Includes restricted stock units.
Remarks:
/s/ Mimi Yang, as Attorney-in-Fact04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did agilon health (AGL) Chief Accounting Officer report on this Form 4?

The Form 4 shows Timothy Gertsch had shares of agilon health Common Stock withheld to cover tax obligations from restricted stock unit settlements, rather than executing open-market sales, while continuing to hold a direct equity position after these routine compensation-related transactions.

How many agilon health (AGL) shares were withheld for taxes in these transactions?

A total of 147 agilon health Common Stock shares were withheld for taxes, with 122 shares on April 15, 2026 at $26.88 per share and 25 shares on April 14, 2026 at $22.68 per share, according to the Form 4 transaction details and footnote disclosure.

Were these agilon health (AGL) Form 4 transactions open-market sales?

No, the Form 4 footnote states the agilon health shares were withheld by the issuer to satisfy income tax withholding and remittance obligations from net settlement of restricted stock units, and explicitly notes these events do not represent sales into the open market by Timothy Gertsch.

How many agilon health (AGL) shares does Timothy Gertsch hold after the transactions?

After the most recent tax-withholding transaction, Timothy Gertsch directly holds 14,177 shares of agilon health Common Stock. This figure, reported in the Form 4, reflects his direct ownership position following the routine withholding of shares to meet income tax obligations.

What is the role of Timothy Gertsch at agilon health (AGL)?

Timothy Gertsch is identified as the Chief Accounting Officer of agilon health, inc. on the Form 4. This officer role means he is a senior finance executive, and his equity transactions are required to be publicly reported under insider reporting rules for company officers.